<code id='16A1A1F087'></code><style id='16A1A1F087'></style>
    • <acronym id='16A1A1F087'></acronym>
      <center id='16A1A1F087'><center id='16A1A1F087'><tfoot id='16A1A1F087'></tfoot></center><abbr id='16A1A1F087'><dir id='16A1A1F087'><tfoot id='16A1A1F087'></tfoot><noframes id='16A1A1F087'>

    • <optgroup id='16A1A1F087'><strike id='16A1A1F087'><sup id='16A1A1F087'></sup></strike><code id='16A1A1F087'></code></optgroup>
        1. <b id='16A1A1F087'><label id='16A1A1F087'><select id='16A1A1F087'><dt id='16A1A1F087'><span id='16A1A1F087'></span></dt></select></label></b><u id='16A1A1F087'></u>
          <i id='16A1A1F087'><strike id='16A1A1F087'><tt id='16A1A1F087'><pre id='16A1A1F087'></pre></tt></strike></i>

          hotspot

          hotspot

          author:hotspot    Page View:783
          Photography of the US department of health and human services in Silver Spring MD
          Manuel Balce Ceneta/AP

          An increasing number of medical device companies are submitting fabricated and unreliable data, the Food and Drug Administration noted Tuesday morning. The data comes from third-party labs hired by device firms to test the quality of their products.

          Triple-check your data or we’ll reject your device, the FDA warned.

          advertisement

          The goal of third-party testing is to ensure a device meets the FDA’s standards in a range of areas, including biocompatibility, sterility, and mechanical performance. The agency wrote that it has noticed an uptick in false data submissions in recent years, particularly from facilities based in China and India. In some cases, the facilities will send data copied from previous device submissions.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          HIV vaccine remains elusive. Immunologists keep trying new ideas
          HIV vaccine remains elusive. Immunologists keep trying new ideas

          SethPincus,ElizabethFischerandAustinAthman,NationalInstituteofAllergyandInfectiousDiseases/NIHHIVhas

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          In diabetes hearing, Sanders takes on a new foe: food makers

          Sen.BerneSanders(I-Vt.)KevinDietsch/GettyImagesWASHINGTON—Sen.BernieSanders(I-Vt.)hasanewcorporateta